INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS FOR EXUDATIVE RETINAL ARTERIAL MACROANEURYSMS

Mansour A. M., Foster R. E., Gallego-Pinazo R., Moschos M. M., Sisk R. A., Chhablani J., ...Daha Fazla

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, cilt.39, sa.6, ss.1133-1141, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 39 Sayı: 6
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1097/iae.0000000000002131
  • Dergi Adı: RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1133-1141
  • Anahtar Kelimeler: aflibercept, anti-vascular endothelial growth factor, bevacizumab, macular edema, optical coherence tomography, optical coherence tomography angiography, ranibizumab, retinal macroaneurysm, MATRIX METALLOPROTEINASES, BEVACIZUMAB, RANIBIZUMAB, THERAPY, COMPLICATIONS, SECONDARY
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Purpose: There is no established therapy for exudative-hemorrhagic complications in primary retinal arteriolar macroaneurysm (RAM).